Lucira Health (LHDX) IPO Opens 30% Higher

February 5, 2021 11:32 AM EST
Get Alerts LHDX Hot Sheet
Price: $7.84 -14.22%

Overall Analyst Rating:
    NEUTRAL (Up Up)

Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Today's IPO for Lucira Health, Inc. (NASDAQ: LHDX) opened for trading at $22.10 after pricing 9,000,000 shares of common stock at a price to the public of $17.00 per share

BofA Securities and William Blair are acting as lead bookrunning managers and LifeSci Capital is acting as co-manager for the offering.

Lucira Health is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. Lucira has developed a testing platform that produces centralized-laboratory-accurate molecular testing in a single-use and consumer-friendly test kit that is powered by two AA batteries and fits in the palm of a hand. Lucira designed its test kits to provide accurate, reliable and on-the-spot molecular test results anywhere and at any time. The LUCIRA COVID-19 All-In-One Test Kit is designed to provide a clinically relevant COVID-19 result within 30 minutes from sample collection.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Hot IPOs, IPOs

Related Entities

William Blair, IPO